WallStreetZenWallStreetZen

NASDAQ: RLAY
Relay Therapeutics Inc Stock Ownership - Who owns Relay Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Relay Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Donald A. BergstromPresident RD2024-03-27765$7.70
$5.89kSell
Peter RahmerTitle Chief Corporate Development Officer2024-03-27298$7.70
$2.29kSell
Brian AdamsChief Legal Officer2024-03-27348$7.70
$2.68kSell
Thomas CatinazzoChief Financial Officer2024-03-27348$7.70
$2.68kSell
Peter RahmerTitle Chief Corporate Development Officer2024-01-291,651$9.64
$15.92kSell
Brian AdamsChief Legal Officer2024-01-291,929$9.64
$18.60kSell
Donald A. BergstromPresident RD2024-01-293,178$9.64
$30.64kSell
Thomas CatinazzoChief Financial Officer2024-01-292,005$9.64
$19.33kSell
Brian AdamsChief Legal Officer2023-12-27294$11.51
$3.38kSell
Donald A. BergstromPresident RD2023-12-27977$11.51
$11.25kSell

1 of 4

RLAY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLAY insiders and whales buy or sell their stock.

RLAY Shareholders

What type of owners hold Relay Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Svf Pauling Cayman Ltd21.27%27,904,963$171.76MInsider
Sb Investment Advisers Uk Ltd21.27%27,904,963$171.76MInstitution
Vanguard Group Inc8.12%10,650,387$65.55MInstitution
Third Rock Ventures Iii LP8.04%10,551,115$64.94MInsider
Blackrock Inc7.30%9,573,423$58.92MInstitution
Price T Rowe Associates Inc6.54%8,581,167$52.82MInstitution
Casdin Capital LLC5.63%7,387,943$45.47MInstitution
Jpmorgan Chase Co4.62%6,065,595$37.33MInstitution
Bellevue Group Ag4.53%5,936,082$36.54MInstitution
State Street Corp3.74%4,903,578$30.18MInstitution

1 of 3

RLAY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLAY72.36%27.64%Net SellingNet Selling
EYPT20.11%79.89%Net SellingNet Buying
ALXO75.63%24.37%Net SellingNet Selling
SAGE71.61%28.39%Net Selling
IMTX58.58%0.00%
View Top Biotech Stocks

Relay Therapeutics Stock Ownership FAQ

Who owns Relay Therapeutics?

Relay Therapeutics (NASDAQ: RLAY) is owned by 96.98% institutional shareholders, 37.04% Relay Therapeutics insiders, and 0.00% retail investors. Svf Pauling Cayman Ltd is the largest individual Relay Therapeutics shareholder, owning 27.90M shares representing 21.27% of the company. Svf Pauling Cayman Ltd's Relay Therapeutics shares are currently valued at $177.75M.

If you're new to stock investing, here's how to buy Relay Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.